This company has been marked as potentially delisted and may not be actively trading. GreenLight Biosciences (GRNA) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Greenlight Coupon CodesApril 21, 2024 | washingtonpost.comSplashdown Quaywest gets green light for £3m upgradeDecember 20, 2023 | bbc.comBroadwalk Shopping Centre redevelopment given green lightSeptember 28, 2023 | bbc.comGreenlight Family Cash Card 2023 ReviewSeptember 19, 2023 | forbes.comGreenLight Biosciences: GreenLight Announces Completion of Merger with Fall Line Endurance FundJuly 24, 2023 | finanznachrichten.deGreenLight Announces Completion of Merger with Fall Line Endurance FundJuly 24, 2023 | finance.yahoo.comTrading was temporarily halted for "GRNA" at 07:07 PM with a stated reason of "News pending."July 24, 2023 | marketbeat.comGreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding SharesJuly 20, 2023 | finance.yahoo.comRNA company to lay off 96 employees in LexingtonJune 13, 2023 | bizjournals.comGRNA ALERT: Levi & Korsinsky, LLP Announces an Investigation of Greenlight BiosciencesJune 5, 2023 | benzinga.comRTP biotech went public a year ago. Now, it's being acquiredJune 1, 2023 | bizjournals.comThe Petri Dish: GreenLight to go private; C4 licenses cancer drug for $392MJune 1, 2023 | bizjournals.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating GreenLight Biosciences Holdings BuyoutMay 31, 2023 | benzinga.comShareholder Alert: Ademi LLP investigates whether GreenLight Biosciences Holdings, PBC has obtained a Fair Price in its transaction with Fall LineMay 30, 2023 | benzinga.comGreenLight Biosciences trades 36% higher on merger agreement with Fall Line Endurance FundMay 30, 2023 | msn.comGreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private TransactionMay 30, 2023 | finance.yahoo.comTrading was temporarily halted for "GRNA" at 06:05 AM with a stated reason of "News pending."May 30, 2023 | marketbeat.comRecap: GreenLight Biosciences Q1 EarningsMay 12, 2023 | msn.comGreenLight Biosciences GAAP EPS of -$0.19 beats by $0.08, revenue of $3.82M beats by $3.32MMay 12, 2023 | msn.comGreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company ProgressMay 11, 2023 | finance.yahoo.comGreenLight Biosciences Releases Inaugural Sustainability ReportApril 12, 2023 | finance.yahoo.comGreenLight Biosciences draws private equity interest; up 10%April 1, 2023 | seekingalpha.comGreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall LineMarch 30, 2023 | finance.yahoo.comGreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial ResultsMarch 28, 2023 | finance.yahoo.comGreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Human Health R&D DayMarch 9, 2023 | finance.yahoo.comGreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Plant Health R&D DayMarch 7, 2023 | finance.yahoo.comGreenlight Screenwriting LabMarch 4, 2023 | bbc.co.ukGreenLight Biosciences to Host R&D Day Series on Plant and Human Health Development StrategyMarch 1, 2023 | finance.yahoo.comGreenLight Biosciences Stock (NASDAQ:GRNA), Quotes and News SummaryFebruary 25, 2023 | benzinga.comGRNA GreenLight Biosciences HoldingsJanuary 27, 2023 | seekingalpha.comAmidst increasing losses, Investors bid up GreenLight Biosciences Holdings (NASDAQ:GRNA) 12% this past weekJanuary 4, 2023 | uk.finance.yahoo.comInsiders who bought this year lost US$169k as GreenLight Biosciences Holdings (NASDAQ:GRNA) sheds US$32m in valueDecember 8, 2022 | finance.yahoo.comCanaccord Genuity Group Begins Coverage on GreenLight Biosciences (NASDAQ:GRNA)Canaccord Genuity Group began coverage on shares of GreenLight Biosciences in a research note on Thursday. They set a "buy" rating and a $4.00 target price on the stock.December 8, 2022 | marketbeat.comPrivate equity firms account for 49% of GreenLight Biosciences Holdings' (NASDAQ:GRNA) ownership, while institutions account for 26%November 11, 2022 | uk.finance.yahoo.comGreenLight Biosciences Announces Third Quarter 2022 Financial Results and Highlights Recent Company ProgressNovember 9, 2022 | finance.yahoo.comGreenLight Biosciences to Participate in Upcoming Investor Conferences in NovemberNovember 7, 2022 | finance.yahoo.comGreen Light Exposure May Help Reduce Pain and HeadachesNovember 1, 2022 | time.comGreenLight Biosciences (NASDAQ:GRNA) Earns Outperform Rating from Analysts at Credit Suisse GroupCredit Suisse Group started coverage on shares of GreenLight Biosciences in a research report on Friday. They set an "outperform" rating and a $5.50 price target on the stock.October 14, 2022 | marketbeat.comFresh off RTP expansion, GreenLight Biosciences now slashing workforce by 25%October 12, 2022 | bizjournals.comGreenLight Biosciences lays off a quarter of its teamOctober 12, 2022 | bizjournals.comGreenLight Biosciences to cut 25% of its workforce as part of ‘realignment’ to extend cash runwayOctober 12, 2022 | msn.comGreenLight Biosciences to Trim Workforce to Adjust to Market ConditionsOctober 12, 2022 | marketwatch.comGreenLight Biosciences announces realignment to focus on near-term value driversOctober 12, 2022 | finance.yahoo.comGreenLight Biosciences and Queensland University of Technology partner to tackle destructive fall armyworm using RNAOctober 5, 2022 | finance.yahoo.comGreenLight Biosciences Holdings (NASDAQ:GRNA) Sees Significant Decline in Short InterestGreenLight Biosciences Holdings (NASDAQ:GRNA - Get Rating) was the recipient of a large decrease in short interest in September. As of September 15th, there was short interest totalling 1,770,000 shares, a decrease of 14.1% from the August 31st total of 2,060,000 shares. Based on an average trading volume of 657,700 shares, the short-interest ratio is currently 2.7 days. Currently, 3.5% of the company's shares are short sold.October 1, 2022 | marketbeat.comInland wind farms are given the green light after seven-year ‘ban’ which meant just one individual could hold up an entire schemeSeptember 26, 2022 | dailymail.co.ukPeering Into GreenLight Biosciences's Recent Short InterestAugust 24, 2022 | msn.comMorningside Venture Investment Acquires 3,061,224 Shares of GreenLight Biosciences Holdings (NASDAQ:GRNA) StockGreenLight Biosciences Holdings (NASDAQ:GRNA - Get Rating) major shareholder Morningside Venture Investment purchased 3,061,224 shares of the company's stock in a transaction on Thursday, August 11th. The shares were purchased at an average price of $3.92 per share, for a total transaction of $11,999,998.08. Following the purchase, the insider now owns 15,919,155 shares in the company, valued at approximately $62,403,087.60. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Large shareholders that own at least 10% of a company's stock are required to disclose their transactions with the SEC.August 15, 2022 | marketbeat.comGreenLight Biosciences announces $109 million financingAugust 12, 2022 | finance.yahoo.comGreenLight Biosciences, Samsung Biologics complete commercial-scale engineering run for mRNA COVID-19 vaccineAugust 3, 2022 | seekingalpha.com Get GreenLight Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address GRNA Media Mentions By Week GRNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GRNA News Sentiment▼0.000.90▲Average Medical News Sentiment GRNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GRNA Articles This Week▼00▲GRNA Articles Average Week Get GreenLight Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DBVT News INMB News TVGN News SGMO News INBX News IPHA News GNFT News FDMT News FATE News MOLN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GRNA) was last updated on 4/27/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GreenLight Biosciences Holdings Please log in to your account or sign up in order to add this asset to your watchlist. Share GreenLight Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GRNA Stock Free GRNA Stock Alerts